| Authors: |
Lukesh NR; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Barbery BG; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Clark KA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Ontiveros-Padilla L; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Ehrenzeller SA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Woodring RN; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Mendell SE; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Middleton DD; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Islam MJ; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Pena ES; Department of Biomedical Engineering, NC State/UNC, Chapel Hill, NC, USA., Hendy DA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Simpson SR; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Graham-Gurysh EG; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Lopez AM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Murphy CT; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Williamson GL; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Ly SA; Department of Biomedical Engineering, NC State/UNC, Chapel Hill, NC, USA., Shilling KE; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Landoni E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Stiepel RT; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Sherwin D; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Genetics, School of Medicine, UNC, Chapel Hill, NC, USA., Ke Q; Department of Microbiology and Immunology, School of Medicine, UNC, Chapel Hill, NC, USA., Savoldo B; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, School of Medicine, UNC, Chapel Hill, NC, USA., Pylayeva-Gupta Y; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Genetics, School of Medicine, UNC, Chapel Hill, NC, USA., Tisch RM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, School of Medicine, UNC, Chapel Hill, NC, USA., Bachelder EM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA., Ainslie KM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, NC, USA. ainsliek@email.unc.edu.; Department of Biomedical Engineering, NC State/UNC, Chapel Hill, NC, USA. ainsliek@email.unc.edu.; Department of Microbiology and Immunology, School of Medicine, UNC, Chapel Hill, NC, USA. ainsliek@email.unc.edu. |
